Home Providence Therapeutics

Providence Therapeutics

In operation
Donation/ Crowdfunding
mRNA Cancer Vaccine Developer
Basic
Enterprise Profile

Basic Information

Providence Therapeutics is a biotechnology company dedicated to developing a personalized mRNA cancer vaccine aimed at treating ovarian cancer. The company's vaccine can identify tumor mutations and trigger an immune response against tumor cells, enabling users to fully treat themselves. Providence Therapeutics aims to provide effective and safe drugs for patients with unmet medical needs.
Providence Therapeutics Holdings, Inc.
Canada
15~50 people
January 01, 2015
info@providencetherapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Technology
Biotechnology
Concept
Vaccination Ovarian Cancer
Application Scenarios
Innovative Drugs Traditional Vaccines (Biological Products for Prevention) Nucleic Acid Drugs